(Q73307130)

English

Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy

scientific article published on 01 December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Hyperfractionated accelerated radiotherapy (HART) for inoperable, nonmetastatic non-small cell lung carcinoma of the lung (NSCLC): results of a phase II study for patients ineligible for combination radiochemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

author name string

S Koutaïssoff

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Wellmann

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Coucke

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Ozsahin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Pampallona

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R O Mirimanoff

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1151-1156

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Therapeutic options for regionally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-doseEn-Bloc radiotherapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensity of neoadjuvant therapy in resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant (induction) treatment for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemotherapy (CT) and radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC): a review

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial experience with a practical hyperfractionated accelerated radiotherapy regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated accelerated radiation therapy for non-small cell lung cancer: clinical phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapidly alternating combination of cisplatin-based chemotherapy and hyperfractionated accelerated radiotherapy in split course for stage IIIA and stage IIIB non-small cell lung cancer: results of a phase I-II study by the GOTHA group. Group d'Oncolo

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological basis of radiation therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor doubling time and prognostic assessment of patients with primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Actual growth rate and tumour cell proliferation in human pulmonary neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of treatment of locally advanced (T3/T4) non-oat cell lung cancer with concomitant boost radiotherapy by the Radiation Therapy Oncology Group (RTOG 83-12): long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900307-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(99)00307-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10613307%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73307130&oldid=1946845323"